Dr Phil Boyle - Low Dose Naltrexone for women's health (2019 Conference) (LDN, low dose naltrexone)

This Presentation was Recorded for The LDN Research Trust 2019 Conference

Hypothyroidism - Dawn Ipsen, PharmD (2021 Conference) (LDN, low dose naltrexone)

Dr. Dawn Ipsen is a compounding pharmacist who presents on some roles low dose naltrexone (LDN) may have in helping patients with hypothyroidism. She discusses hypothyroidism, its prevalence, and treatment goals. 

Autoimmune thyroiditis Part 3 - Kent Holtorf, MD (2021 Conference) (LDN, low dose naltrexone)

This is Part 3 of Dr. Holtorf’s 3-part series on autoimmune thyroiditis as a core cause of hypothalamic pituitary dysfunction, mitochondrial dysfunction, obesity and systemic illness. This last segment will bring it all together and give practical ways to use this information. 

Autoimmune thyroiditis Part 2 - Kent Holtorf, MD (2021 Conference) (LDN, low dose naltrexone)

This is Part 2 of Dr. Holtorf’s 3-part series on autoimmune thyroiditis as a core cause of hypothalamic pituitary dysfunction, mitochondrial dysfunction, obesity and systemic illness

Autoimmune thyroiditis Part 1 - Kent Holtorf, MD (2021 Conference) (LDN, low dose naltrexone)

Autoimmunity in Families - Sarah Zielsdorf, MD, MS (2021 Conference) (LDN, low dose naltrexone)

A Non-Invasive First Approach Toward Idiopathic Female Infertility - Sarah Zielsdorf, MD, MS (2021 Conference) (LDN, low dose naltrexone)

Olga Cortez, MD - LDN Use in Women's Health II (2019 Conference) (LDN, low dose naltrexone)

Olga Cortez, MD - LDN Use in Women's Health I (2019 Conference) (LDN, low dose naltrexone)